Welcome to
SYNAGEVA
Discovering and Developing Drugs for Unmet Medical Needs
Overview
Providing Doctor-Approved Medicines & Developing Drugs for Unmet Medical Needs
Synageva is a biopharmaceutical company given to the discovery and development of medicines for patients with rare diseases. We take responsibility for and commit to the health and well-being of patients.
We Care
Hence, we ensure strict adherence to policies with our research.
Featured Posts
Developing New Medicines
Numerous studies and research carried out have set a precedent for the development of new orphan drugs. Biopharmaceuticals, as the name implies, are biologically sourced. Since they're usually large molecule proteins and nucleic acids, developing them follows a strict...
Discovering Active Principles
Scientists usually isolate active principles or compounds from natural products for the formation of drugs. However, biopharmaceutical formulations differ slightly from generic pharmaceuticals. That's because they're heterogeneous mixtures with large molecular...
The Unmet Medical Needs of Rare Disease Conditions
Presently, the concept of essential medicines prevails in the healthcare industry. Therefore, it's inevitable that patients with conditions don't ail the majority of the population get left out. This issue is paramount and is gaining traction as governments enact...
4 Customer Experience Improvement Tips to Adopt in the Pharmaceutical Industry
5 Routes to Safe Medication AdministrationIt’s no news that the pharmaceutical industry is one of the fastest-growing in the world. Due to its sensitive nature and the massive responsibilities that come with being a much-needed and precious sector, the need to...
5 Routes to Safe Medication Administration
5 Routes to Safe Medication Administration Medical errors stand as the third leading cause of death in the United States of America after cancer and heart diseases, claiming about 250 000 lives yearly. The errors include delayed and misdiagnosis, medication error,...
DevelopMent
Developing New Medicines
Numerous studies and research carried out have set a precedent for the development of new orphan drugs. Biopharmaceuticals, as the name implies, are biologically sourced. Since they’re usually large molecule proteins and nucleic acids, developing them follows a strict process. Examples include recombinant proteins and monoclonal antibodies, such as those used in cancer treatments.
Phone
(609) 469-0350
Location
150 Lincoln Street
Laurel Springs, NJ 08021
info@synageva.com
Work Hours
M-F: 8am – 5pm
S-S: 9am – 4pm